Evotec announces intent to acquire preclinical CRO Cyprotex
Evotec has made an offer to acquire Cyprotex PLC, a preclinical contract research organization (CRO) specializing in ADME-Tox and DMPK.
Archives for October 25, 2016
Report: Australia 60% cheaper than US for clinical trials
With a tax incentive program making clinical trials up to 60% more cost-effective, Australia is a “gateway” to larger studies throughout Asia, says CRO.
Pfizer fined for hazardous chemical violations at Puerto Rico plant
The US Environmental Protection Agency (EPA) has fined Pfizer $190,000 for failing to disclose that it had ammonia and methylamine at its facility in Barceloneta, Puerto Rico.
US FDA still worried about Interpharm's efforts to stop API data manipulation
The US FDA wants more information on Czech API firm Interpharm Praha AS’s efforts to prevent repetition of data manipulation uncovered during 2015 inspection.
Cel-Sci working to have Multikine trial partial hold lifted after receiving formal US FDA letter
Cel-Sci has received written confirmation the US FDA has placed a late stage trial of its cancer cell therapy Multikine on partial clinical hold a month after agency first raised concerns.
update - Kaleo wants all patients to have access to Auvi-Q, regardless of insurance coverage
Kaleo set to relaunch withdrawn Epipen rival Auvi-Q next year
Kaleo has said it will relaunch Auvi-Q (epinephrine injection) a year after a recall by licensee Sanofi removed the Epipen rival from the market.
Fake drug sales mean fewer people are employed by EU drug firms says EUIPO
Drug counterfeiting means the EU pharmaceutical industry employs 37,700 fewer people than it otherwise would, according to the European Union Intellectual Property Office (EUIPO).